Brain Metastases in HER2-Positive Breast Cancer: Current and Novel Treatment Strategies by Alejandro Garcia-Alvarez, Andri Papakonstantinou, Mafalda Oliveira

Get full text

Recycling and Application of Mine Tailings in Alkali-Activated Cements and Mortars—Strength Development and Environmental Assessment by Nuno Cristelo, João Coelho, Mafalda Oliveira, Nilo Cesar Consoli, Ángel Palomo, Ana Fernández-Jiménez

Get full text

Facemasks during aerobic exercise: Implications for cardiac rehabilitation programs during the Covid-19 pandemic by Tiago Pimenta, Helena Tavares, João Ramos, Mafalda Oliveira, David Reis, Hugo Amorim, Afonso Rocha

Get full text

Avaliação de conhecimentos sobre exposição solar by Rita Meireles Pedro, Catarina Sá Couto, Daniela Almeida Ribeiro, Mafalda Oliveira, Raquel Lisboa, Sandra Mimoso Guedes

Get full text

Surviving critical COVID-19: How functionality, physical, mental and cognitive outcomes evolve? by Ana Teixeira-Vaz, José Afonso Rocha, Mafalda Oliveira, Tiago Simões-Moreira, David Almeida E Reis, Ana Isabel Silva, José Artur Paiva

Get full text

Next Generation-Targeted Amplicon Sequencing (NG-TAS): an optimised protocol and computational pipeline for cost-effective profiling of circulating tumour DNA by Meiling Gao, Maurizio Callari, Emma Beddowes, Stephen-John Sammut, Marta Grzelak, Heather Biggs, Linda Jones, Abdelhamid Boumertit, Sabine C. Linn, Javier Cortes, Mafalda Oliveira, Richard Baird, Suet-Feung Chin, Carlos Caldas

Get full text

First Nationwide Molecular Screening Program in Spain for Patients With Advanced Breast Cancer: Results From the AGATA SOLTI-1301 Study by Sonia Pernas, Sonia Pernas, Patricia Villagrasa, Ana Vivancos, Maurizio Scaltriti, Jordi Rodón, Jordi Rodón, Octavio Burgués, Paolo Nuciforo, Jordi Canes, Laia Paré, Marta Dueñas, Marta Dueñas, Maria Vidal, Maria Vidal, Maria Vidal, Juan Miguel Cejalvo, Juan Miguel Cejalvo, Juan Miguel Cejalvo, Antonia Perelló, Antonio Llommbard-Cussac, Joan Dorca, Alvaro Montaño, Tomás Pascual, Mafalda Oliveira, Mafalda Oliveira, Gloria Ribas, Gloria Ribas, Inmaculada Rapado, Aleix Prat, Aleix Prat, Aleix Prat, Aleix Prat, Eva Ciruelos, Eva Ciruelos

Get full text

Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial by Tomás Pascual, Mafalda Oliveira, Patricia Villagrasa, Vanesa Ortega, Laia Paré, Begoña Bermejo, Serafín Morales, Kepa Amillano, Rafael López, Patricia Galván, Jordi Canes, Fernando Salvador, Paolo Nuciforo, Isabel T. Rubio, Antonio Llombart-Cussac, Serena Di Cosimo, José Baselga, Nadia Harbeck, Aleix Prat, Javier Cortés

Get full text

The AURORA pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group by Marion Maetens, David Brown, Alexandre Irrthum, Philippe Aftimos, Giuseppe Viale, Sibylle Loibl, Jean-François Laes, Peter J. Campbell, Alastair Thompson, Javier Cortes, Sabine Seiler, Sara Vinnicombe, Mafalda Oliveira, Françoise Rothé, Yacine Bareche, Debora Fumagalli, Dimitrios Zardavas, Christine Desmedt, Martine Piccart, Sherene Loi, Christos Sotiriou

Get full text

Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy by Tomás Pascual, Aranzazu Fernandez-Martinez, Yash Agrawal, Adam D. Pfefferle, Nuria Chic, Fara Brasó-Maristany, Blanca Gonzàlez-Farré, Laia Paré, Guillermo Villacampa, Cristina Saura, Cristina Hernando, Montserrat Muñoz, Patricia Galván, Xavier Gonzàlez-Farré, Mafalda Oliveira, Miguel Gil-Gil, Eva Ciruelos, Patricia Villagrasa, Joaquín Gavilá, Aleix Prat, Charles M. Perou

Get full text

HOPE (SOLTI-1903) breast cancer study: real-world, patient-centric, clinical practice study to assess the impact of genomic data on next treatment decision-choice in patients with... by Rubén Olivera-Salguero, Elia Seguí, Elia Seguí, Elia Seguí, Juan Miguel Cejalvo, Juan Miguel Cejalvo, Mafalda Oliveira, Mafalda Oliveira, Mafalda Oliveira, Pablo Tolosa, Pablo Tolosa, Maria Vidal, Maria Vidal, Maria Vidal, Maria Vidal, Marcos Malumbres, Marcos Malumbres, Marcos Malumbres, Joaquín Gavilá, Joaquín Gavilá, Cristina Saura, Cristina Saura, Sonia Pernas, Sonia Pernas, Rafael López, Rafael López, Mireia Margelí, Mireia Margelí, Judith Balmaña, Judith Balmaña, Montserrat Muñoz, Montserrat Muñoz, Montserrat Muñoz, Isabel Blancas, Isabel Blancas, Valentina Boni, Valentina Boni, Eva Ciruelos, Eva Ciruelos, Eva Ciruelos, Elena Galve, Elena Galve, Antonia Perelló, Antonia Perelló, Rodrigo Sánchez-Bayona, Rodrigo Sánchez-Bayona, Susana de la Cruz, Susana de la Cruz, Miguel de la Hoya, Patricia Galván, Esther Sanfeliu, Esther Sanfeliu, Esther Sanfeliu, Blanca Gonzalez-Farre, Blanca Gonzalez-Farre, Blanca Gonzalez-Farre, Valeria Sirenko, Aura Blanch-Torras, Jordi Canes, Helena Masanas, Rosa Olmos, Margarita Forns, Aleix Prat, Aleix Prat, Aleix Prat, Aleix Prat, Ana Casas, Ana Casas, Tomás Pascual, Tomás Pascual

Get full text

Oestrogen receptor activity in hormone-dependent breast cancer during chemotherapy by Nuria Chic, Francesco Schettini, Fara Brasó-Maristany, Esther Sanfeliu, Barbara Adamo, Maria Vidal, Débora Martínez, Patricia Galván, Blanca González-Farré, Javier Cortés, Joaquín Gavilá, Cristina Saura, Mafalda Oliveira, Sònia Pernas, Olga Martínez-Sáez, Jesús Soberino, Eva Ciruelos, Lisa A. Carey, Montserrat Muñoz, Charles M. Perou, Tomás Pascual, Meritxell Bellet, Aleix Prat

Get full text

Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade by Fara Brasó-Maristany, Gaia Griguolo, Tomás Pascual, Laia Paré, Paolo Nuciforo, Antonio Llombart-Cussac, Begoña Bermejo, Mafalda Oliveira, Serafín Morales, Noelia Martínez, Maria Vidal, Barbara Adamo, Olga Martínez, Sonia Pernas, Rafael López, Montserrat Muñoz, Núria Chic, Patricia Galván, Isabel Garau, Luis Manso, Jesús Alarcón, Eduardo Martínez, Sara Gregorio, Roger R. Gomis, Patricia Villagrasa, Javier Cortés, Eva Ciruelos, Aleix Prat

Get full text

Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer by Aleix Prat, Fara Brasó-Maristany, Olga Martínez-Sáez, Esther Sanfeliu, Youli Xia, Meritxell Bellet, Patricia Galván, Débora Martínez, Tomás Pascual, Mercedes Marín-Aguilera, Anna Rodríguez, Nuria Chic, Barbara Adamo, Laia Paré, Maria Vidal, Mireia Margelí, Ester Ballana, Marina Gómez-Rey, Mafalda Oliveira, Eudald Felip, Judit Matito, Rodrigo Sánchez-Bayona, Anna Suñol, Cristina Saura, Eva Ciruelos, Pablo Tolosa, Montserrat Muñoz, Blanca González-Farré, Patricia Villagrasa, Joel S. Parker, Charles M. Perou, Ana Vivancos

Get full text

Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP) by Luis Manso, Cristina Hernando, María Galán, Mafalda Oliveira, Miguel A. Cabrera, Raquel Bratos, César A. Rodríguez, Manuel Ruiz-Borrego, Salvador Blanch, Antonio Llombart-Cussac, Juan I. Delgado-Mingorance, Iñaki Álvarez-Busto, Isabel Gallegos, Lucía González-Cortijo, Serafín Morales, Elena Aguirre, Blanca A. Hernando, Ana Ballesteros, José E. Alés-Martínez, Cristina Reboredo, Amparo Oltra, María González-Cao, Marta Santisteban, Diego Malón, Isabel Echeverría, Elisa García-Garre, Estela Vega, Sònia Servitja, Raquel Andrés, Carlos E. Robles, Rafael López, Elena Galve, María J. Echarri, Marta Legeren, Fernando Moreno

Get full text

High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer by Marta Palafox, Laia Monserrat, Meritxell Bellet, Guillermo Villacampa, Abel Gonzalez-Perez, Mafalda Oliveira, Fara Brasó-Maristany, Nusaibah Ibrahimi, Srinivasaraghavan Kannan, Leonardo Mina, Maria Teresa Herrera-Abreu, Andreu Òdena, Mònica Sánchez-Guixé, Marta Capelán, Analía Azaro, Alejandra Bruna, Olga Rodríguez, Marta Guzmán, Judit Grueso, Cristina Viaplana, Javier Hernández, Faye Su, Kui Lin, Robert B. Clarke, Carlos Caldas, Joaquín Arribas, Stefan Michiels, Alicia García-Sanz, Nicholas C. Turner, Aleix Prat, Paolo Nuciforo, Rodrigo Dienstmann, Chandra S. Verma, Nuria Lopez-Bigas, Maurizio Scaltriti, Monica Arnedos, Cristina Saura, Violeta Serra

Get full text

Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer by Marta Palafox, Laia Monserrat, Meritxell Bellet, Guillermo Villacampa, Abel Gonzalez-Perez, Mafalda Oliveira, Fara Brasó-Maristany, Nusaibah Ibrahimi, Srinivasaraghavan Kannan, Leonardo Mina, Maria Teresa Herrera-Abreu, Andreu Òdena, Mònica Sánchez-Guixé, Marta Capelán, Analía Azaro, Alejandra Bruna, Olga Rodríguez, Marta Guzmán, Judit Grueso, Cristina Viaplana, Javier Hernández, Faye Su, Kui Lin, Robert B. Clarke, Carlos Caldas, Joaquín Arribas, Stefan Michiels, Alicia García-Sanz, Nicholas C. Turner, Aleix Prat, Paolo Nuciforo, Rodrigo Dienstmann, Chandra S. Verma, Nuria Lopez-Bigas, Maurizio Scaltriti, Monica Arnedos, Cristina Saura, Violeta Serra

Get full text